US 10214522
Anti-alphavbeta1 integrin inhibitors and methods of use
granted A61PA61P1/16A61P11/00
Quick answer
US patent 10214522 (Anti-alphavbeta1 integrin inhibitors and methods of use) held by The Regents of the University of California expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P13/12, A61P17/00